↓ Skip to main content

Cochrane Database of Systematic Reviews

Penfluridol for schizophrenia

Overview of attention for article published in Cochrane database of systematic reviews, April 2006
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (94th percentile)
  • High Attention Score compared to outputs of the same age and source (82nd percentile)

Mentioned by

blogs
1 blog
twitter
8 X users
weibo
1 weibo user
wikipedia
2 Wikipedia pages

Citations

dimensions_citation
36 Dimensions

Readers on

mendeley
108 Mendeley
Title
Penfluridol for schizophrenia
Published in
Cochrane database of systematic reviews, April 2006
DOI 10.1002/14651858.cd002923.pub2
Pubmed ID
Authors

Bernardo GO Soares, Mauricio Silva de Lima

Abstract

Penfluridol, available since 1970, is an unusual long acting oral antipsychotic agent for the treatment of schizophrenia. It may be considered a depot medication as it is administered once a week.

X Demographics

X Demographics

The data shown below were collected from the profiles of 8 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 108 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Denmark 1 <1%
Unknown 107 99%

Demographic breakdown

Readers by professional status Count As %
Student > Master 15 14%
Student > Ph. D. Student 11 10%
Student > Bachelor 11 10%
Researcher 9 8%
Student > Doctoral Student 8 7%
Other 24 22%
Unknown 30 28%
Readers by discipline Count As %
Medicine and Dentistry 28 26%
Psychology 16 15%
Nursing and Health Professions 7 6%
Pharmacology, Toxicology and Pharmaceutical Science 5 5%
Biochemistry, Genetics and Molecular Biology 3 3%
Other 13 12%
Unknown 36 33%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 15. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 16 October 2019.
All research outputs
#2,420,580
of 25,457,858 outputs
Outputs from Cochrane database of systematic reviews
#4,913
of 11,842 outputs
Outputs of similar age
#4,997
of 84,969 outputs
Outputs of similar age from Cochrane database of systematic reviews
#8
of 47 outputs
Altmetric has tracked 25,457,858 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 90th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 11,842 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 38.9. This one has gotten more attention than average, scoring higher than 58% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 84,969 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 94% of its contemporaries.
We're also able to compare this research output to 47 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 82% of its contemporaries.